Evaluation of Ginseng on indices of chronic stress in patients with the metabolic syndrome

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-05000636

Enrollment

Unknown

Registered

2005-09-08

Start date

2001-11-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gland and Hormone Related Diseases

Interventions

Two groups:Ginseng capsule versus placebo, 12 weeks

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Adult patients with mild to moderate diabetes mellitus

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Changes in fasting and 2hr plasma glucose after a oral glucose tolerance test;	—

Secondary

Measure	Time frame
markers of oxidative stress, inflammation and endothelial function;	—

Countries

China

Contacts

Public ContactBrian Tomlinson

btomlinson@cuhk.edu.hk

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026